Dr. Chiu specializes in cancer research and biomedical signal transduction. As the company’s Chief Biomedical Scientist, her work centers on the clinical application of biomarkers, validating their diagnostic and prognostic value through clinical specimens. She has extensive experience leading government projects and coordinating interdisciplinary collaborations across engineering and science, driving advances in diagnostic technologies and their successful commercialization.

In developing biochip diagnostic platforms, she bridges clinical needs with technology, overseeing clinical trial design and execution. During the COVID-19 pandemic, Dr. Chiu demonstrated full-spectrum expertise from R&D to regulatory review, co-developing a diagnostic product that completed clinical trials and obtained tFDA EUA approval, contributing significantly to the company’s technology and product deployment.